We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,642

Court certifies class in hospital merger antitrust lawsuit
  • McDermott Will & Emery
  • USA
  • December 19 2013

On December 10, 2013, Judge Edmond Chang of the Northern District of Illinois certified a class of plaintiffs who filed a proposed class action


Advocate General Jääskinen gives Georgetown University SPC opinion
  • McDermott Will & Emery
  • European Union, Netherlands, United Kingdom
  • December 16 2013

On 14 November 2013, Advocate General (AG) Jääskinen's opinion in the Dutch supplementary protection certificate (SPC) referral, Georgetown


CMS extends start date for stage 3 of meaningful use to 2017 without extending timeline for stage 2
  • McDermott Will & Emery
  • USA
  • December 12 2013

The Centers for Medicare & Medicaid Services recently announced a revised timeline for the implementation of Stage 3 “meaningful use” measures for


Employer shared responsibility payments and reporting requirements under the Affordable Care Act: Code Sections 6055 and 6056
  • McDermott Will & Emery
  • USA
  • September 13 2014

There are two types of employer shared responsibility payments, also known as pay or play penalties, under the Affordable Care Act (ACA). The first


CMS proposed rule revisits PBM pricing arrangements, proposes other Medicare Advantage and Part D program changes
  • McDermott Will & Emery
  • USA
  • May 19 2008

Proposed changes to the Medicare Advantage, Medicare Marketing, Part D and Retiree Drug Subsidy Programs include mandatory use of “pass-through” methodology for Part D drugs and new marketing requirements


AAMCAAU Joint Advisory Committee issues new guidelines on managing conflicts of interest
  • McDermott Will & Emery
  • USA
  • February 28 2008

This highly visible report makes several recommendations designed to accelerate implementation of effective policies that address both individual and institutional financial conflicts of interest


Court challenges threaten ACA premium tax credits in state with federal facilitated exchanges
  • McDermott Will & Emery
  • USA
  • January 2 2014

Two federal district court judges will likely rule in early 2014 on pending challenges to the availability of premium tax credits under the Patient


IRS capitalized legal fees incurred by pharmaceutical company
  • McDermott Will & Emery
  • USA
  • April 15 2013

In a recently released Field Attorney Advice, the Internal Revenue Service (IRS) Office of Chief Counsel concluded that a pharmaceutical company must


CMS to postpone denying claims when orderingreferring provider not enrolled in Medicare
  • McDermott Will & Emery
  • Australia
  • December 3 2013

The Centers for Medicare & Medicaid Services will implement edits on providers orderingreferring Part B, durable medical equipment and Part A home


Proof of conception of invention is not confined to any formula
  • McDermott Will & Emery
  • USA
  • December 31 2013

Analyzing whether proof of conception of a DNA segment invention required a showing of the entire polynucleotide sequence, the U. S. Court of Appeals